Added to YB: 2025-11-17
Pitch date: 2025-11-12
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+24.16%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 28.5B
Pitch Price
EUR 29.00
Price Target
N/A
Dividend
0.38%
EV/EBITDA
7.40
P/E
-144.19
EV/Sales
1.33
Sector
Pharmaceuticals
Category
turnaround
Bayer (BAYN Germany): operational lift from Crop Science, but litigation still overshadows the story
BAYN.DE (quick overview): Adj EBITDA +15% vs expectations driven by Crop Science margin recovery from efficiency programs. Pharma/Consumer Health in-line. Reiterated FY outlook but glyphosate litigation provisions expanded to €4B. CEO targets containment by 2026. Operational turnaround solid but re-rating capped until legal clarity.
Read full article (2 min)